New hope for chinese adults with Hard-to-Treat leukemia
NCT ID NCT05687032
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called inotuzumab ozogamicin in 44 Chinese adults whose acute lymphoblastic leukemia (ALL) had come back or stopped responding to treatment. The drug targets a protein called CD22 on leukemia cells to destroy them. The main goal was to see how many patients achieved complete remission, meaning no signs of cancer in the bone marrow or blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, 350000, China
-
Guangzhou First People's Hospital
Guangzhou, Guangdong, 510180, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450008, China
-
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, Tianjin Municipality, 300020, China
-
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, 301600, China
-
NanFang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510700, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
-
The First Affiliated Hospital of Wenzhou Medical College
Wenzhou, Zhejiang, 325000, China
-
The First Hospital of Harbin
Harbin, Heilongjiang, 150010, China
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
-
The first Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310003, China
-
Tongji Hospital, Tongji Medical College,Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
-
Union Hospital, Tongji Medical College of Huazhong University of Science & Technology
Wuhan, Hubei, 430022, China
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China